Endothelial actions of atrial and B-type natriuretic peptides

被引:89
作者
Kuhn, Michaela [1 ]
机构
[1] Univ Wurzburg, Inst Physiol, D-97070 Wurzburg, Germany
关键词
atrial natriuretic peptide; B-type natriuretic peptide; guanylyl cyclase-A; cGMP; endothelial cells; permeability; angiogenesis; ACTIVATED PROTEIN-KINASE; CYCLASE-A RECEPTOR; GUANYLYL CYCLASE; PULMONARY-EDEMA; MICE LACKING; BARRIER DYSFUNCTION; PLASMA-VOLUME; ALPHA-HANP; LUNG; CGMP;
D O I
10.1111/j.1476-5381.2012.01827.x
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
The cardiac hormone atrial natriuretic peptide (ANP) is critically involved in the maintenance of arterial blood pressure and intravascular volume homeostasis. Its cGMP-producing GC-A receptor is densely expressed in the microvascular endothelium of the lung and systemic circulation, but the functional relevance is controversial. Some studies reported that ANP stimulates endothelial cell permeability, whereas others described that the peptide attenuates endothelial barrier dysfunction provoked by inflammatory agents such as thrombin or histamine. Many studies in vitro addressed the effects of ANP on endothelial proliferation and migration. Again, both pro- and anti-angiogenic properties were described. To unravel the role of the endothelial actions of ANP in vivo, we inactivated the murine GC-A gene selectively in endothelial cells by homologous loxP/Cre-mediated recombination. Our studies in these mice indicate that ANP, via endothelial GC-A, increases endothelial albumin permeability in the microcirculation of the skin and skeletal muscle. This effect is critically involved in the endocrine hypovolaemic, hypotensive actions of the cardiac hormone. On the other hand the homologous GC-A-activating B-type NP (BNP), which is produced by cardiac myocytes and many other cell types in response to stressors such as hypoxia, possibly exerts more paracrine than endocrine actions. For instance, within the ischaemic skeletal muscle BNP released from activated satellite cells can improve the regeneration of neighbouring endothelia. This review will focus on recent advancements in our understanding of endothelial NP/GC-A signalling in the pulmonary versus systemic circulation. It will discuss possible mechanisms accounting for the discrepant observations made for the endothelial actions of this hormone-receptor system and distinguish between (patho)physiological and pharmacological actions. Lastly it will emphasize the potential therapeutical implications derived from the actions of NPs on endothelial permeability and regeneration.
引用
收藏
页码:522 / 531
页数:10
相关论文
共 94 条
[81]   DISTRIBUTION OF ATRIAL NATRIURETIC POLYPEPTIDE (ANP)-CONTAINING CELLS IN THE RAT-HEART AND PULMONARY VEIN - IMMUNOHISTOCHEMICAL STUDY AND RADIOIMMUNOASSAY [J].
TOSHIMORI, H ;
NAKAZATO, M ;
TOSHIMORI, K ;
ASAI, J ;
MATSUKURA, S ;
OURA, C ;
MATSUO, H .
CELL AND TISSUE RESEARCH, 1988, 251 (03) :541-546
[82]   ATRIAL-NATRIURETIC-FACTOR DECREASES WHOLE-BODY CAPILLARY ABSORPTION IN RATS [J].
TRIPPODO, NC ;
BARBEE, RW .
AMERICAN JOURNAL OF PHYSIOLOGY, 1987, 252 (05) :R915-R920
[83]   Atrial natriuretic peptide inhibits tumor necrosis factor-alpha production by interferon-gamma-activated macrophages via suppression of p38 mitogen-activated protein kinase and nuclear factor-kappa B activation [J].
Tsukagoshi, H ;
Shimizu, Y ;
Kawata, T ;
Hisada, T ;
Shimizu, Y ;
Iwamae, S ;
Ishizuka, T ;
Iizuka, K ;
Dobashi, K ;
Mori, M .
REGULATORY PEPTIDES, 2001, 99 (01) :21-29
[84]   UNCOUPLING OF ATRIAL-NATRIURETIC-PEPTIDE EXTRACTION AND CYCLIC GUANOSINE-MONOPHOSPHATE PRODUCTION IN THE PULMONARY CIRCULATION IN PATIENTS WITH SEVERE HEART-FAILURE [J].
TSUTAMOTO, T ;
KANAMORI, T ;
WADA, A ;
KINOSHITA, M .
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 1992, 20 (03) :541-546
[85]   TISSUE-SPECIFIC EFFECTS OF PHYSIOLOGICAL ANP INFUSION ON BLOOD-TISSUE ALBUMIN TRANSPORT [J].
TUCKER, VL ;
SIMANONOK, KE ;
RENKIN, EM .
AMERICAN JOURNAL OF PHYSIOLOGY, 1992, 263 (04) :R945-R953
[86]   Effects of atrial natriuretic peptide on phagocytosis and respiratory burst in murine macrophages [J].
Vollmar, AM ;
Forster, R ;
Schulz, R .
EUROPEAN JOURNAL OF PHARMACOLOGY, 1997, 319 (2-3) :279-285
[87]   Hypoxia, via stabilization of the hypoxia-inducible factor HIF-1α, is a direct and sufficient stimulus for brain-type natriuretic peptide induction [J].
Weidemann, Alexander ;
Klanke, Bernd ;
Wagner, Michael ;
Volk, Tilmann ;
Willam, Carsten ;
Wiesener, Michael S. ;
Eckardt, Kai-Uwe ;
Warnecke, Christina .
BIOCHEMICAL JOURNAL, 2008, 409 :233-242
[88]   PRIMING OF POLYMORPHONUCLEAR NEUTROPHILS BY ATRIAL-NATRIURETIC-PEPTIDE INVITRO [J].
WIEDERMANN, CJ ;
NIEDERMUHLBICHLER, M ;
BRAUNSTEINER, H .
JOURNAL OF CLINICAL INVESTIGATION, 1992, 89 (05) :1580-1586
[89]   Potential therapeutic gene for the treatment of ischemic disease:: Ad2/hypoxia-inducible factor-1α ( HIF-1)/VP16 enhances b-type natriuretic peptide gene expression via a HIF-1-responsive element [J].
Wilhide, Michael E. ;
Jones, W. Keith .
MOLECULAR PHARMACOLOGY, 2006, 69 (06) :1773-1778
[90]   Atrial natriuretic peptide protects against Staphylococcus aureus-induced lung injury and endothelial barrier dysfunction [J].
Xing, Junjie ;
Moldobaeva, Nurgul ;
Birukova, Anna A. .
JOURNAL OF APPLIED PHYSIOLOGY, 2011, 110 (01) :213-224